Bulut, G. Et Al. 2019. Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells. Future Oncology , vol.16, no.3 , 4485-4495.

Bulut, G., ATMACA İLHAN, H., & Karaca, B., (2019). Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells. Future Oncology , vol.16, no.3, 4485-4495.

Bulut, Gulcan, HARİKA ATMACA İLHAN, And Burcak Karaca. "Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells," Future Oncology , vol.16, no.3, 4485-4495, 2019

Bulut, Gulcan Et Al. "Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells." Future Oncology , vol.16, no.3, pp.4485-4495, 2019

Bulut, G. ATMACA İLHAN, H. And Karaca, B. (2019) . "Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells." Future Oncology , vol.16, no.3, pp.4485-4495.

@article{article, author={Gulcan Bulut Et Al. }, title={Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells}, journal={Future Oncology}, year=2019, pages={4485-4495} }